Production (Stage)
TG Therapeutics, Inc.
TGTX
$35.15
-$0.09-0.26%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -11.18% | -8.81% | 56.98% | 3.56% | -3.55% |
| Total Receivables | 47.17% | 11.63% | 38.42% | 28.66% | 27.18% |
| Inventory | 42.82% | 30.46% | 4.22% | 4.53% | 95.16% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 29.74% | -51.84% | 363.06% | -12.95% | -14.96% |
| Total Current Assets | 13.80% | -1.34% | 47.52% | 7.92% | 13.41% |
|
|
|||||
| Total Current Assets | 13.80% | -1.34% | 47.52% | 7.92% | 13.41% |
| Net Property, Plant & Equipment | -3.13% | -3.51% | -3.29% | -3.88% | -0.97% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.80% | -1.09% | -1.10% | 30.03% | -26.24% |
| Total Assets | 13.67% | -1.42% | 46.06% | 7.47% | 13.27% |
|
|
|||||
| Total Accounts Payable | 256.83% | -65.85% | 7.14% | -0.55% | 146.89% |
| Total Accrued Expenses | -66.18% | 50.57% | 58.79% | 76.51% | -70.44% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.46% | 47.68% | -27.03% | -1.06% | -5.44% |
| Total Finance Division Other Current Liabilities | 25.06% | 28.78% | 27.95% | 30.02% | 111.14% |
| Total Other Current Liabilities | 25.06% | 28.78% | 27.95% | 30.02% | 111.14% |
| Total Current Liabilities | 76.68% | -27.52% | 15.14% | 9.01% | 85.56% |
|
|
|||||
| Total Current Liabilities | 76.68% | -27.52% | 15.14% | 9.01% | 85.56% |
| Long-Term Debt | 0.12% | 0.11% | 138.12% | 1.20% | 1.21% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.36% | -3.40% | -3.17% | -2.96% | -2.94% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -45.40% | -25.24% | 331.90% | 15.38% | -46.08% |
| Total Liabilities | 18.03% | -9.78% | 76.11% | 4.89% | 26.10% |
|
|
|||||
| Common Stock & APIC | 0.91% | 0.77% | 0.74% | 2.90% | -1.63% |
| Retained Earnings | 0.33% | 1.50% | 0.25% | -2.05% | 1.77% |
| Treasury Stock & Other | -68.08% | -277.42% | -918.38% | 0.00% | 0.00% |
| Total Common Equity | 6.71% | 15.72% | 8.22% | 10.90% | -0.24% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.71% | 15.72% | 8.22% | 10.90% | -0.24% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 6.71% | 15.72% | 8.22% | 10.90% | -0.24% |
|
|
|||||